Your location:Home page > Program
George Lau
Share the:
Humanity & Health Medical Group/The 5th Medical Centre of Chinese PLA General Hospital

Professor George Lau graduated from The Faculty of Medicine, The University of Hong Kong in 1987. In 1992, he was awarded Hong Kong-Stanford scholarship for his further training in Gastroenterology and Hepatology at the Stanford University. In 1998, he was recommended by Professor Roger Williams to be further trained in translational Hepatology at the Institute of Hepatology, University College of London. In 2006, he was promoted to full Clinical Professor and assistant Dean, Faculty of Medicine, The University of Hong Kong. He was elected as 19th President of The Asian Pacific Association for the Study of the Liver (APASL) in 2008. In 2009, he founded and become Chairman and Consultant in Gastroenterology and Hepatology, Humanity and Health Medical Group, Hong Kong. Concurrently, he was appointed as the Co-director and Chair Professor at Liver disease and Transplant Center, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China. Dr. Lau’s research interest is immunotherapy in liver diseases. Throughout his 3 decades of research, he has published over >300 original articles (including NEJM, Lancet, J Hepatol, Hepatology and Hepatology International) with a citations of 39,000+ and a H-index of 93. Notably, Dr Lau is the lead author for the phase 3 pegylated interferon for CHB in 2005 and HIMALAYA study for HCC in 2022. Currently, he is also the chairman of the APASL HBV reactivation guidelines committee and COVID-19 taskforce, Co-chairman of the APASL HBV guideline committee, panel member of the APASL HCV and HCC guideline committee.


廖家杰,男,中国人民解放军总医院第五医学中心,肝病内科,教授。 长期从事乙型肝炎病毒(HBV)、丙型肝炎病毒(HCV)感染的临床、基础及转化医学研究工作,是国际知名的HBV、HCV抗病毒治疗临床试验的领导者,曾作为首席研究员开展聚乙二醇干扰素治疗慢性乙肝的临床研究项目,目前已经成为HBV抗病毒治疗领域的一个里程碑性研究成果。廖教授在多种国际知名学术期刊发表学术论文300余篇,总引用次数超过6000次,经常受邀到全球各地进行专题讲座。 

2002年当选为香港十大杰出青年。2008-2009年当选为第19届亚太地区肝脏病研究协会(APASL)。廖教授是Journal of Hepatology 和Liver international杂志的副主编,并担任20多种国际期刊的特约审稿人,是美国肝脏病研究协会(AASLD)、欧洲肝脏病研究协会(EASL)、亚太地区肝脏病研究协会(APASL)等多个学术委员会的成员。曾任香港大学医学院肠胃和肝脏科临床教授、医学院助理院长和香港中药全球化联盟秘书长,目前是香港和北京天下仁心肠胃和肝脏科中心的主任。

The lecture video:0

Abstract:10

1177

0

0

The academic assignments are as follows
Date (UTC+8) Time (UTC+8) Local Time Room Session Role Talk Title
2022-09-16 14:05-14:25 2022-09-16,14:05-14:25Meeting Room 1

Postgraduate Course 2 - Basic and Clinical Research in Viral Hepatitis

Speaker Definition of HBV cure and treatment endpoint
2022-09-17 08:00-09:30 2022-09-17,08:00-09:30Meeting Room 1

State-of-the-art Session 2

Moderator